Literature DB >> 3664430

Carcinoid tumors of the thymus. An immunohistochemical study.

W M Herbst1, W Kummer, W Hofmann, H Otto, C Heym.   

Abstract

Five carcinoid tumors of the thymus were screened immunohistochemically for the occurrence of neuropeptides (ACTH, calcitonin, calcitonin gene-related peptide, cholecystokinin, gastrin, neurotensin, somatostatin, substance P), as well as of serotonin, chromogranin A, and neuron-specific enolase. Most of the patients exhibited local symptoms evoked by growing tumor masses in the upper mediastinum without any clinical evidence of endocrine activity. Light and electron microscopic examination showed characteristic uniform large epithelial cells in polar or palisade arrangement, containing variable amounts of electron-dense secretory granules. Only a few of the tested neuropeptide antisera reacted with the investigated tumors. Cholecystokinin-immunoreactive cell populations were seen in all tumors. Expression of neurotensin could be observed in three neoplasms, two of which also exhibited ACTH immunoreactivity. Chromogranin A-immunoreactive cells were found in two neoplasms. Neuron-specific enolase showed strong staining in three tumors, one of the tumors also being immunoreactive for calcitonin. The results were confirmed by control reactions. Apart from the demonstration that conventional marker proteins are not reliable in identifying all carcinoid tumors, the present study proves that the visualization of neuropeptide-immunoreactive cells in thymus carcinoids does not necessarily correspond to the manifestation of the clinical symptoms. Furthermore, each of the investigated neoplasms, as also known from other carcinoid tumors, appears to be able to produce more than one hormone.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3664430     DOI: 10.1002/1097-0142(19871115)60:10<2465::aid-cncr2820601020>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

Review 1.  Primary thymic carcinoid with Cushing's syndrome.

Authors:  G Wollensak; E W Herbst; A Beck; H E Schaefer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Cells immunoreactive for neuropeptide in human thymomas.

Authors:  L Lauriola; N Maggiano; L M Larocca; F O Ranelletti; R Ricci; M Piantelli; A Capelli
Journal:  J Clin Pathol       Date:  1990-10       Impact factor: 3.411

Review 3.  Tumours of the thymus and their nomenclature.

Authors:  H F Otto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  Giant thymic carcinoid.

Authors:  L C John; P Hornick; S Lang; J Wallis; S J Edmondson
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

5.  Carcinoid tumors of the thymus.

Authors:  S Venkatesh; N A Samaan
Journal:  West J Med       Date:  1990-01

Review 6.  The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors.

Authors:  P Rosa; H H Gerdes
Journal:  J Endocrinol Invest       Date:  1994-03       Impact factor: 4.256

7.  Carcinoid tumours of the thymus.

Authors:  D Y Wang; D B Chang; S H Kuo; P C Yang; Y C Lee; H C Hsu; K T Luh
Journal:  Thorax       Date:  1994-04       Impact factor: 9.139

8.  Steroid production in the thymus: implications for thymocyte selection.

Authors:  M S Vacchio; V Papadopoulos; J D Ashwell
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

9.  Cholinergic epithelial cell with chemosensory traits in murine thymic medulla.

Authors:  Alexandra Regina Panneck; Amir Rafiq; Burkhard Schütz; Aichurek Soultanova; Klaus Deckmann; Vladimir Chubanov; Thomas Gudermann; Eberhard Weihe; Gabriela Krasteva-Christ; Veronika Grau; Adriana del Rey; Wolfgang Kummer
Journal:  Cell Tissue Res       Date:  2014-10-10       Impact factor: 5.249

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.